RecruitingNot ApplicableNCT07034924

Temporary Aortic Compression With the Abdominal Tourniquet for Refractory Postpartum Hemorrhage

Sponsor

LLC UkrMedGroup

Enrollment

20 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Postpartum Hemorrhage

Summary

This multicenter study aims to evaluate effectiveness and safety of using the AAJT-S device as a temporary intervention for severe, atony-related PPH that is refractory to standard therapies

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Abdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S) for people with postpartum hemorrhage. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAbdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S)

The AAJT-S is a non-invasive, externally applied medical device designed to achieve temporary occlusion of the abdominal aorta and inferior vena cava by inflating a pneumatic bladder to 250 mmHg. In this study, the device will be used as a temporizing measure for patients with severe postpartum hemorrhage unresponsive to standard uterotonics and balloon tamponade. The device will be applied horizontally over the upper abdomen and inflated using a built-in pressure gauge. The intended effect is to reduce pelvic blood flow and allow time for mobilization of surgical resources and blood transfusion. Maximum application time will not exceed 60 minutes, in accordance with established safety guidelines.